New Drug Used to Treat Advanced Melanoma Patients
There’s new hope for people who suffer from melanoma, one of the deadliest forms of cancer.
UCLA researchers performed preliminary tests on a new drug called lambrolizumab.
They found 38 percent of advanced melanoma patients taking the medication saw improvement with their cancer.
Researchers say the drug reactivates the body’s immune system to fight off cancer cells and has no serious side effects.
The Food and Drug Administration labeled it a breakthrough drug in April.